AMARIN CORP PLC\UK Payments of Stock Issuance Costs
AMARIN CORP PLC\UK (AMRN) reported Payments of Stock Issuance Costs of $504.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-01
- AMARIN CORP PLC\UK payments of stock issuance costs for the quarter ending 2020-12-31 was $238.00K.
- AMARIN CORP PLC\UK payments of stock issuance costs for the quarter ending 2020-09-30 was $28.00K.
- AMARIN CORP PLC\UK payments of stock issuance costs for the quarter ending 2018-12-31 was $0.00.
- AMARIN CORP PLC\UK payments of stock issuance costs for fiscal 2020 was $504.00K.
- AMARIN CORP PLC\UK payments of stock issuance costs for fiscal 2018 was $39.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $266.00K derived: sum of 2 quarters · filed 2023-03-01 | $504.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $266.00K 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $238.00K 10-Q · filed 2021-08-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $39.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $39.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |